Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a ...

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

Syros Pharmaceuticals (SYRS – Research Report) received a Hold rating and price target from JMP Securities analyst Jason Butler today.

Syros Pharmaceuticals' Phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome did not meet primary endpoints, ...

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that the ...

The SELECT-MDS-1 trial showed no significant complete response rate improvement with tamibarotene plus azacitidine for ...

Syros Pharmaceuticals (SYRS) Company Description: Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary ...

Syros Pharmaceuticals announced that its phase 3 trial of tamibarotene in combination with azacitidine did not meet the primary endpoint for the treatment of myelodysplastic syndrome.

The American College of Lifestyle Medicine (ACLM) has announced that Nathan Pritikin, the nutritionist, inventor and longevity researcher known for pioneering lifestyle approaches to the treatment and ...

Vanda Pharmaceuticals Inc. (Vanda) today announced that the company will participate in the following upcoming investor conferences in November ...

People inherit two copies of each gene -; one from each parent -; an evolutionary fail-safe to ensure survival even when one of them doesn't function.

Certain indoor plants can help improve air quality by absorbing pollutants and releasing oxygen. Plants like snake plants, peace lilies, and spider plants are known for their air-purifying properties ...